Study compares single-inhaler triple therapies for treatment of COPD
For patients with chronic obstructive pulmonary disease (COPD), budesonide-glycopyrrolate-formoterol does not improve ...
News Medical on MSN3d
Study finds no clinical advantage of budesonide inhaler over fluticasone in COPD
A study compares budesonide-glycopyrrolate-formoterol and fluticasone-umeclidinium-vilanterol, revealing insights on COPD ...
Four chronic lung conditions that worsen in winter as expert shares tips for staying safe
Dr. Andy Whittamore, a GP and clinical lead at Asthma and Lung UK, shed light on four chronic lung conditions that tend to ...
2minutemedicine.com1d
Different single inhaler triple therapies appear to have similar clinical outcomes for chronic obstructive pulmonary disease
In a cohort of adults with chronic obstructive pulmonary disease (COPD), receiving fluticasone-umeclidinium-vilanterol was ...
The Daily Item1d
Valve procedure is life changing for woman with lung diseases
For the past 10 years, medications and inhalers began to help less and less with Rose Walsh’s breathing problems. Battling ...
Synairgen (LON:SNG) Trading Up 33.3% – Here’s What Happened
Synairgen plc (LON:SNG – Get Free Report)’s share price shot up 33.3% during trading on Monday . The company traded as high as GBX 3 ($0.04) and last traded at GBX 3 ($0.04). 205,983 shares changed ...